• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Recognized Consensus Standards

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | Registration & Listing | Adverse Events | Recalls | PMA | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

New Search Back To Search Results
Recognition List Number: 029 Publication Date: 08/20/2012 

Part B: SUPPLEMENTARY INFORMATION

Recognition Number 7-200: CLSI M48-A, Laboratory Detection and Identification of Mycobacteria; Approved Guideline. (InVitro Diagnostics)

Date of Standard: 2008. 
Address of Standards Organization:
  Clinical Laboratory Standards Institute (CLSI)
  950 West Valley Road
  Suite 2500
  Wayne, PA 19087
 
CDRH Office and Division Associated with Recognized Standards:
OFFICE OF IN VITRO DIAGNOSTICS AND RADIOLOGICAL HEALTH (OIR)
DIVISION OF MICROBIOLOGY (DMD)
Devices Affected:
Mycobacterium tuberculosis immunofluorescent reagents regulated under 21 CFR 866.3370 and Microorganism differentiation and identification device under 21 CFR 866.2600
Processes Affected:
510(k), pre-IDE
Type of Standard:
 Vertical, National
Extent of Recognition:
Partial recognition; Methodology accepted but not interpretive criteria when it differs from those in CDER approved drug package inserts
Related CFR Citations and Product Codes:
 
Regulation
Number
Device Name Device
Class
Product
Code
§866.2660 Kit, Identification, Mycobacteria Class 1 JSY
 
Regulation
Number
Device Name Device
Class
Product
Code
§866.3370 Antiserum, Fluorescent, Mycobacterium Tuberculosis Class 1 GRT
§866.3370 Assay, Nucleic Acid Amplification, Growth Identification, Mycobacterium Tuberculosis Class 1 NDZ
§866.3370 Dna-Reagents, Mycobacterium Spp. Class 1 LQF
§866.3370 System, Mycolic Acid Analysis, Mycobacterium Tuberculosis Class 1 NJO
 
Relevant Guidance:
1. Review Criteria for Assessment of In Vitro Diagnostic Devices for Direct Detection of Mycobacterium Spp. [Tuberculosis(TB)]
FDA Technical Contacts:
  Janice Washington
  FDA/CDRH/OIVD
  10903 New Hampshire Avenue Building 66, Room 5554
  Silver Spring MD 20993
  301/796-6207
  Email: janice.washington@fda.hhs.gov
  Patricia Conville
  FDA/CDRH/OIVD
  10903 New Hampshire Avenue Building 66, Room 5510
  Silver Spring MD 20993
  301/796-6942
  Email: patricia.conville@fda.hhs.gov
-
-